Company: KAVL
Filing Date: 2025-02-21
Form Type: PRE 14C
Source: 0001731122-25-000278
Chunk: 1

Company: Kaival Brands Innovations Group, Inc.
Filing Date: 2025-02-21
Form: PRE 14C
Chunk 1
---
 the issued and outstanding
shares of the Company’s common stock, par value $0.001 (the “Shares” or “Common Stock”), at a ratio of any
whole number within the range between one-for-two (1:2) and one-for-twenty (1:20), with such ratio to be determined in the discretion
of the Registrant’s Board of Directors and with such action to be effected at such time and date as determined by the Board of Directors
(the “Reverse Split”).

The Reverse Split was authorized
and approved by the Unanimous Written Consent of the Board of Directors dated February 21, 2025 and by the Action by Written Consent of
the Stockholders holding the majority of the voting power of the Company, dated February [ ], 2025.

In accordance with Rule 14c-2 of
the Exchange Act, corporate actions described above will be effective no earlier than twenty (20) days after this Information Statement
has been mailed to our stockholders, which we expect to be on or approximately [*], 2025.

This Information Statement has
been mailed to you for information purposes only on or about [*], 2025, and you are not required to take any action.

PLEASE NOTE THAT THIS IS NOT A NOTICE OF A MEETING OF STOCKHOLDERS AND NO STOCKHOLDERS MEETING WILL BE HELD TO CONSIDER THE MATTERS DESCRIBED HEREIN.

| By Order of the Board of Directors: |
| /s/                                 |
| Mark Thoenes                        |
| Chief Executive Officer             |
| [*], 2025                           |

<div align='center'>2

KAIVAL BRANDS INNOVATIONS GROUP, INC.

4460 Old Dixie Highway

Grant-Valkaria, Florida 32949

Information Statement Pursuant to Section 14C of the Securities Exchange Act of 1934</div>

This Information Statement is being filed by Kaival
Brands Innovations Group., (the “Company”, or “Registrant”) with the United States Securities and Exchange Commission
(the “SEC”) on [ ], 2025, based upon the Written Consent of the Board of Directors dated February 21, 2025 (the “Board
Consent”) and the consent of the holders of a majority of outstanding shares of voting capital stock of the Company (the “Majority
Consenting Stockholders”) dated February [ ], 2025 (the “Stockholder Consent” and, together with the Board Consent,